UMN Pharma Inc. announced consolidated earnings results for the first quarter ended March 31, 2015. For the quarter, the company announced net sales of JPY 42 million against JPY 70 million a year ago. Operating loss was JPY 485 million against JPY 1,111 million a year ago. Ordinary loss was JPY 461 million against JPY 1,195 million a year ago. Net loss was JPY 457 million or JPY 47.86 per basic share against JPY 904 million or JPY 107.14 per basic share a year ago. Net cash outflow from operating activities was JPY 848,714,000 against net cash flow from operating activities of JPY 2,073,493,000 a year ago. Purchase of property, plant and equipment was JPY 1,400,000 compared to JPY 310,000 for the same period a year ago. Purchases of intangible fixed assets were JPY 216,000. Loss before income taxes and minority interests was JPY 461,436,000 against JPY 948,209,000 a year ago.

The company provided earnings guidance for the full year ending December 31, 2015. For the full year ending December 31, 2015, the company expects to report net sales of JPY 5,224 million, operating loss of JPY 878 million, ordinary loss of JPY 1,025 million and net loss of JPY 1,033 million or JPY 108.14 per share.